VBP Pains Swell Prompting New China Strategy, Local Innovation Focus

Drug Makers Tap Into Local Innovation

China slowdown
China VBP pressure prompts big pharma to tap into local innovation in a strategy shift • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia